Fingerprint
Dive into the research topics of 'Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors
Johanna M. Schafer, Brian D. Lehmann, Paula I. Gonzalez-Ericsson, Clayton B. Marshall, J. Scott Beeler, Lindsay N. Redman, Hailing Jin, Violeta Sanchez, Matthew C. Stubbs, Peggy Scherle, Kimberly N. Johnson, Quanhu Sheng, Joseph T. Roland, Joshua A. Bauer, Yu Shyr, Bapsi Chakravarthy, Bret C. Mobley, Scott W. Hiebert, Justin M. Balko, Melinda E. Sanders
Research output: Contribution to journal › Article › peer-review
37
Citations
(Scopus)